Fig. 4From: Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?Biodistribution data (% ID/g) of [177Lu]Lu-PSMA-10 ([177Lu]Lu-1), [177Lu]Lu-3, [177Lu]Lu-10 and [177Lu]Lu-11 in tumor xenograft-bearing CB17-SCID mice at 24 h p.i. (n = 4 for [177Lu]Lu-10 and n = 5 for all other experiments). Submandibular and parotid glands were dissected separately and their values are depicted in the columns ‚GL. SUBMAND.‘and ‚GL. PAROTIDEA‘, respectivelyBack to article page